The Effect of Donor Rat Gender in Mitochondrial Transplantation Therapy of Cisplatin-Induced Toxicity on Rat Renal Proximal Tubular Cells

被引:4
作者
Arjmand, Abdollah [1 ]
Faizi, Mehrdad [1 ]
Rezaei, Mohsen [2 ]
Pourahmad, Jalal [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Toxicol & Pharmacol, Tehran, Iran
[2] Tarbiat Modares Univ, Fac Med Sci, Dept Toxicol, Tehran, Iran
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2023年 / 22卷 / 01期
关键词
Cisplatin; Oxidative Stress; Nephrotoxicity; Mitochondrial Transplantation; INDUCED NEPHROTOXICITY; SEX-DIFFERENCES; AMELIORATION; MECHANISMS; COMPLEXES; TRANSPORT; FAILURE; STRESS; DEATH; LUNG;
D O I
10.5812/ijpr-135666
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Cisplatin-induced nephrotoxicity has been linked to a fundamental mechanism of mitochondrial dysfunction. A treatment called mitochondrial transplantation therapy can be used to replace damaged mitochondria with healthy mitochondria. Mitochondrial-related diseases may benefit from this approach. Objectives: We investigated the effect of mitochondrial transplantation on cisplatin-induced nephrotoxicity using freshly isolated mitochondria obtained from renal proximal tubular cells (RPTCs). Methods: Based on our previous findings, we hypothesized that direct exposure of healthy mitochondria to cisplatin-affected RPTCs might improve cytotoxicity markers and restore mitochondrial function. Therefore, the primary objective of this study was to determine whether newly isolated mitochondrial transplantation protected RPTCs from cisplatin-induced cytotoxicity. The supply of exogenous rat kidney mitochondria to cisplatin-affected RPTCs was also a goal of this study to investigate the possibility of gender differences. After the addition of cisplatin (100 & mu;M), rat RPTCs (106 cells/mL) were suspended in Earle's solution (pH = 7.4) at 37 & DEG;C for two hours. Freshly isolated mitochondria were extracted at 4 & DEG;C and diluted in 100 and 200 & mu;g/mL mitochondrial protein. Results: Statistical analysis revealed that transplantation of healthy mitochondria decreased ROS level, mitochondrial membrane potential (MMP) collapse, MDA level, glutathione depletion, lysosomal membrane damage, and caspase-3 activity induced by cisplatin in rat RPTCs. In addition, our results demonstrated that transplantation of female rat kidney mitochondria has higher protective activity at reducing toxicity parameters than male mitochondria. Conclusions: The findings reaffirmed that mitochondrial transplantation is a novel, potential, and promising therapeutic strategy for xenobiotic-induced nephrotoxicity.
引用
收藏
页数:15
相关论文
共 50 条
[1]   Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment [J].
Aleksunes, Lauren M. ;
Augustine, Lisa M. ;
Scheffer, George L. ;
Cherrington, Nathan J. ;
Manautou, Jose E. .
TOXICOLOGY, 2008, 250 (2-3) :82-88
[2]   MITOCHONDRIAL TRANSMEMBRANE POTENTIAL AND PH GRADIENT DURING ANOXIA [J].
ANDERSSON, BS ;
AW, TY ;
JONES, DP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (04) :C349-C355
[3]   Naringenin attenuates cisplatin nephrotoxicity in rats [J].
Badary, OA ;
Abdel-Maksoud, S ;
Ahmed, WA ;
Owieda, GH .
LIFE SCIENCES, 2005, 76 (18) :2125-2135
[4]   Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells [J].
Baek, SM ;
Kwon, CH ;
Kim, JH ;
Woo, JS ;
Jung, JS ;
Kim, YK .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2003, 142 (03) :178-186
[5]   Cisplatin: a review of toxicities and therapeutic applications [J].
Barabas, K. ;
Milner, R. ;
Lurie, D. ;
Adin, C. .
VETERINARY AND COMPARATIVE ONCOLOGY, 2008, 6 (01) :1-18
[6]   Rhodamine 123 as a probe of mitochondrial membrane potential:: evaluation of proton flux through F0 during ATP synthesis [J].
Baracca, A ;
Sgarbi, G ;
Solaini, G ;
Lenaz, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2003, 1606 (1-3) :137-146
[7]   INHIBITION OF LIPID-PEROXIDATION PROMOTED BY IRON(III) AND ASCORBATE [J].
BEACH, DC ;
GIROUX, E .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 297 (02) :258-264
[8]  
Bereiter-Hahn Juergen, 2008, Biotechnology Journal, V3, P765, DOI 10.1002/biot.200800024
[9]  
BOOM SPA, 1992, J PHARMACOL EXP THER, V263, P445
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3